Matches in SemOpenAlex for { <https://semopenalex.org/work/W2790551110> ?p ?o ?g. }
- W2790551110 endingPage "2644" @default.
- W2790551110 startingPage "2637" @default.
- W2790551110 abstract "Conventional cancer targeting with nanoparticles has been based on the assumed enhanced permeability and retention (EPR) effect. The data obtained in clinical trials to date, however, have rarely supported the presence of such an effect. To address this challenge, we formulated intracellular nitric oxide-generating nanoparticles (NO-NPs) for the tumor site-specific delivery of NO, a well-known vasodilator, with the intention of boosting EPR. These nanoparticles are self-assembled under aqueous conditions from amphiphilic copolymers of poly(ethylene glycol) and nitrated dextran, which possesses inherent NO release properties in the reductive environment of cancer cells. After systemic administration of the NO-NPs, we quantitatively assessed and visualized increased tumor blood flow as well as enhanced vascular permeability than could be achieved without NO. Additionally, we prepared doxorubicin (DOX)-encapsulated NO-NPs and demonstrated consequential improvement in therapeutic efficacy over the control groups with considerably improved DOX intratumoral accumulation. Overall, this proof of concept study implies a high potency of the NO-NPs as an EPR enhancer to achieve better clinical outcomes." @default.
- W2790551110 created "2018-03-29" @default.
- W2790551110 creator A5000953547 @default.
- W2790551110 creator A5016844009 @default.
- W2790551110 creator A5017792494 @default.
- W2790551110 creator A5044491242 @default.
- W2790551110 creator A5056586797 @default.
- W2790551110 creator A5062229729 @default.
- W2790551110 creator A5072689710 @default.
- W2790551110 creator A5073677422 @default.
- W2790551110 creator A5079257522 @default.
- W2790551110 creator A5084616347 @default.
- W2790551110 creator A5084694805 @default.
- W2790551110 creator A5088253355 @default.
- W2790551110 creator A5090608920 @default.
- W2790551110 date "2018-03-09" @default.
- W2790551110 modified "2023-10-14" @default.
- W2790551110 title "Intracellularly Activatable Nanovasodilators To Enhance Passive Cancer Targeting Regime" @default.
- W2790551110 cites W1119734502 @default.
- W2790551110 cites W1148781016 @default.
- W2790551110 cites W1479760463 @default.
- W2790551110 cites W1677499164 @default.
- W2790551110 cites W1968583232 @default.
- W2790551110 cites W1976041621 @default.
- W2790551110 cites W1978549014 @default.
- W2790551110 cites W2019154265 @default.
- W2790551110 cites W2035342960 @default.
- W2790551110 cites W2056211275 @default.
- W2790551110 cites W2057593306 @default.
- W2790551110 cites W2062753806 @default.
- W2790551110 cites W2065374619 @default.
- W2790551110 cites W2067562016 @default.
- W2790551110 cites W2069072174 @default.
- W2790551110 cites W2070003597 @default.
- W2790551110 cites W2072415644 @default.
- W2790551110 cites W2080559907 @default.
- W2790551110 cites W2082412592 @default.
- W2790551110 cites W2088659772 @default.
- W2790551110 cites W2090458427 @default.
- W2790551110 cites W2092175186 @default.
- W2790551110 cites W2094305477 @default.
- W2790551110 cites W2099797949 @default.
- W2790551110 cites W2116118767 @default.
- W2790551110 cites W2139438973 @default.
- W2790551110 cites W2143463421 @default.
- W2790551110 cites W2148357124 @default.
- W2790551110 cites W2165002516 @default.
- W2790551110 cites W2177205490 @default.
- W2790551110 cites W2177921096 @default.
- W2790551110 cites W2554773181 @default.
- W2790551110 doi "https://doi.org/10.1021/acs.nanolett.8b00495" @default.
- W2790551110 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29521509" @default.
- W2790551110 hasPublicationYear "2018" @default.
- W2790551110 type Work @default.
- W2790551110 sameAs 2790551110 @default.
- W2790551110 citedByCount "65" @default.
- W2790551110 countsByYear W27905511102018 @default.
- W2790551110 countsByYear W27905511102019 @default.
- W2790551110 countsByYear W27905511102020 @default.
- W2790551110 countsByYear W27905511102021 @default.
- W2790551110 countsByYear W27905511102022 @default.
- W2790551110 countsByYear W27905511102023 @default.
- W2790551110 crossrefType "journal-article" @default.
- W2790551110 hasAuthorship W2790551110A5000953547 @default.
- W2790551110 hasAuthorship W2790551110A5016844009 @default.
- W2790551110 hasAuthorship W2790551110A5017792494 @default.
- W2790551110 hasAuthorship W2790551110A5044491242 @default.
- W2790551110 hasAuthorship W2790551110A5056586797 @default.
- W2790551110 hasAuthorship W2790551110A5062229729 @default.
- W2790551110 hasAuthorship W2790551110A5072689710 @default.
- W2790551110 hasAuthorship W2790551110A5073677422 @default.
- W2790551110 hasAuthorship W2790551110A5079257522 @default.
- W2790551110 hasAuthorship W2790551110A5084616347 @default.
- W2790551110 hasAuthorship W2790551110A5084694805 @default.
- W2790551110 hasAuthorship W2790551110A5088253355 @default.
- W2790551110 hasAuthorship W2790551110A5090608920 @default.
- W2790551110 hasConcept C120882062 @default.
- W2790551110 hasConcept C12554922 @default.
- W2790551110 hasConcept C141071460 @default.
- W2790551110 hasConcept C150903083 @default.
- W2790551110 hasConcept C155672457 @default.
- W2790551110 hasConcept C15920480 @default.
- W2790551110 hasConcept C171250308 @default.
- W2790551110 hasConcept C178790620 @default.
- W2790551110 hasConcept C185592680 @default.
- W2790551110 hasConcept C192562407 @default.
- W2790551110 hasConcept C207001950 @default.
- W2790551110 hasConcept C21951064 @default.
- W2790551110 hasConcept C2776694085 @default.
- W2790551110 hasConcept C2777339698 @default.
- W2790551110 hasConcept C2777516009 @default.
- W2790551110 hasConcept C2779820397 @default.
- W2790551110 hasConcept C2781303535 @default.
- W2790551110 hasConcept C41625074 @default.
- W2790551110 hasConcept C519581460 @default.
- W2790551110 hasConcept C521977710 @default.
- W2790551110 hasConcept C55493867 @default.
- W2790551110 hasConcept C67407626 @default.